<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04923646</url>
  </required_header>
  <id_info>
    <org_study_id>FIT1</org_study_id>
    <nct_id>NCT04923646</nct_id>
  </id_info>
  <brief_title>Veteran Primers for CRC Screening</brief_title>
  <official_title>Primers to Improve Adherence to Annual CRC Screening Among Veterans: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Puget Sound Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Puget Sound Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial to evaluate the effectiveness of targeted outreach&#xD;
      reminder strategies for a population-based, mailed, fecal immunochemistry test kit (FIT)&#xD;
      screening program at the VA Puget Sound among average risk patients who are due for annual&#xD;
      colorectal cancer (CRC) screening.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized controlled trial that will evaluate the effectiveness of&#xD;
      two different targeted outreach interventions at increasing colorectal cancer (CRC) screening&#xD;
      rates, within the VA Puget Sound Health Care System. Average risk patients who are due for&#xD;
      annual CRC screening (defined as aged 50-75 with no previous history of CRC, not under&#xD;
      hospice care, and alive at the time of screening) will be identified through administrative&#xD;
      data. All patients who are due for CRC screening will be mailed a fecal immunochemical test&#xD;
      (FIT) kit, kit instructions, and a standard introductory letter from the primary care clinics&#xD;
      at the VA Puget Sound. Two weeks following the mailing of the kits, patients who have not&#xD;
      returned a kit will be identified for participation in the trial.&#xD;
&#xD;
      Patients eligible for enrollment into the trial will be randomized in a 1:1:1 allocation&#xD;
      using permuted block randomization (with random block sizes of 3 and 6 ) to the following&#xD;
      interventions:&#xD;
&#xD;
        1. Control arm - receives no reminders,&#xD;
&#xD;
        2. Arm 2 - receives a standard automated reminder phone call,&#xD;
&#xD;
        3. Arm 3 - receives an automated reminder phone call with behavioral messaging,&#xD;
&#xD;
      Randomization will be stratified within arms by prior screening status (prior screener vs.&#xD;
      never screener.&#xD;
&#xD;
      Our primary outcome of interest is the return rate at three months post randomization. Our&#xD;
      secondary outcome of interest is the return rate at six months post randomization. Additional&#xD;
      exploratory analyses will include sub-group analyses by race/ethnicity and reach. Enrollment&#xD;
      in the trial will occur between March 1, 2021 and May 1, 2021.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 30, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Return proportion</measure>
    <time_frame>3 months</time_frame>
    <description>Percent of returned FIT tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Return proportion</measure>
    <time_frame>6 months</time_frame>
    <description>Percent of returned FIT tests</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2404</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Primer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No Primer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Primer</intervention_name>
    <description>Mailed postcard notifying Veteran of upcoming FIT kit for annual CRC screening.</description>
    <arm_group_label>Active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligible participants are automatically enrolled in this project. We are unable to enroll&#xD;
        participants upon request.&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  Veteran&#xD;
&#xD;
          -  Assigned to a primary care provider at the VA Puget Sound as of January 1, 2021&#xD;
&#xD;
          -  At least 1 year of prior data available (evidence of at least one outpatient visit)&#xD;
&#xD;
          -  Due for annual colorectal (CRC) screening&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Not scheduled for either a screening or diagnostic colonoscopy within the 12 weeks&#xD;
             from assessment.&#xD;
&#xD;
          -  Not currently receiving hospice care&#xD;
&#xD;
          -  No record of recent death in the administrative data.&#xD;
&#xD;
          -  No history of CRC or history of prior colectomy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashok Reddy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Puget Sound Health Care System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefanie Deeds, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Puget Sound Health Care System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefanie Deeds, MD</last_name>
    <phone>206-314-0507</phone>
    <email>stefanie.deeds@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alaina Mori</last_name>
    <phone>206-247-6782</phone>
    <email>alaina.mori@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Stefanie Deeds, MD</last_name>
      <phone>206-314-0507</phone>
      <email>stefanie.deeds@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Alaina Mori, BA</last_name>
      <phone>206-247-6782</phone>
      <email>alaina.mori@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Ashok Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Geyer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefanie Deeds, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Linnaea Schuttner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 19, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VA Puget Sound Health Care System</investigator_affiliation>
    <investigator_full_name>Linnaea Schuttner</investigator_full_name>
    <investigator_title>Staff Physician</investigator_title>
  </responsible_party>
  <keyword>Cancer screening</keyword>
  <keyword>Behavioral economics</keyword>
  <keyword>Adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

